Cargando…
New Oral Anticoagulants in Acute Coronary Syndrome: Is There Any Advantage Over Existing Treatments?
BACKGROUND: After an acute coronary syndrome, dual antiplatelet therapy with clopidogrel plus aspirin is still a standard of care, but several new approaches have been investigated. OBJECTIVES: The present study re-examined the studies published thus far on this topic to evaluate the effectiveness o...
Autores principales: | Messori, Andrea, Fadda, Valeria, Gatto, Roberta, Maratea, Dario, Trippoli, Sabrina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Safnek
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109037/ https://www.ncbi.nlm.nih.gov/pubmed/25177676 |
Ejemplares similares
-
Testing the Therapeutic Equivalence of Alogliptin, Linagliptin, Saxagliptin, Sitagliptin or Vildagliptin as Monotherapy or in Combination with Metformin in Patients with Type 2 Diabetes
por: Messori, Andrea, et al.
Publicado: (2014) -
Subcutaneous Biological Treatments for Moderate to Severe Psoriasis: Interpreting Safety Data by Network Meta-Analysis
por: Messori, Andrea, et al.
Publicado: (2015) -
Biological drugs for inducing remission in patients with Crohn's disease: determining statistical equivalence according to evidence-based methods
por: Messori, Andrea, et al.
Publicado: (2015) -
Managing Tenders in the Procurement of Advanced Medical Devices: An Original Model Based on the Net Monetary Benefit Combined With Three Clinical Endpoints
por: Messori, Andrea, et al.
Publicado: (2023) -
Simplified figure to present direct and indirect comparisons: Revisiting the graph 10 years later
por: Fadda, Valeria, et al.
Publicado: (2021)